Science fiction turned reality: 5 key challenges to be addressed – Schwab
WEF founder and executive chairman Klaus Schwab looks at five of the major challenges on the horizon as we enter a new world where science fiction is turned into reality.
Biotechnology
Future perfect: GSK, Alphabet create Galvani to cure arthiritis, diabetes
GlaxoSmithKline, the U.K.’s biggest drugmaker, has created a £540m joint venture called Galvani with Google parent Alphabet’s life-sciences business to research and develop bioelectronic medicines.
Klaus Schwab: Navigating the Fourth Industrial Revolution
Klaus Schwab unpacks the Fourth Industrial Revolution, which is building on the Third (the digital revolution that has been occurring since the middle of the last century).
WEF 2016: 4th Industrial Revolution. 5mn jobs, women in the firing line.
The Fourth Industrial Revolution is expected to take centre stage at WEF 2016 to be held in Davos this week. The problem with revolutions, there’s always going to be winners and losers.
Raymond McCauley forewarned, forearmed: in-house DNA kits
Singularity University’s biotechnology and bioinformatics expert Raymond McCauley says developments in DNA research is transforming the world we live in.
Whispers of biotech bubble bursting worries Wall Street
A number of SA financial advisors are punting American biotech stocks after an amazing run that looks suspiciously like the dot com bubble of the late 1990s
Bloomberg View: Lee Kuan Yew’s Growth Model Needs Radical Rethink
With the gap between haves and have-nots widening and citizens turning against the open immigration policies Singapore long embraced, the Southeast Asian city-state is facing stark questions about its identity.
Shares surge to best week in two years, QE spark creates roaring fire
The Biznews Global Share Portfolio is on a rip. Then again so is pretty much every sensible constructed share portfolio, not just those focused abroad.
Asian stocks steady as China GDP growth hits target
By Wayne Cole SYDNEY (Reuters) – Asian stocks held stubbornly steady on Wednesday after China reported economic growth that was just ahead of market expectations, drawing a sigh of relief from investors rather than outright applause. China’s economy expanded by 2.0 percent in the second quarter from the previous quarter, taking annual growth to 7.5 percent. Retail … Read more
Regrow’s Dr Satyen Sangvhi on the power and promise of stem cells
Stem cell therapy is not new – nor is the ethical, religious and philosophical controversy surrounding it. Routine therapeutic  use has so far been limited to blood-forming stem cells that derive from the body’s  bone marrow, peripheral blood, or umbilical cord blood. The most well-known  of this type of therapy, and the only one in common use worldwide, is bone … Read more